Hold Biocon, says Anu Jain

Jain told CNBC-TV18, "Biocon is a stock in pharmaceutical which has taken a batting down and its taken support, now consolidating, looking that it’s consolidating and moving out of the range. So at Rs 232 where it closed it becomes a buy, I would use dips till about Rs 229-228 with a stop loss of about Rs 225- 226."

She further added, "I think the immediate target is Rs 243 even as an investment stock playing up to Rs 280 I think it’s a good stock to hold on to. So I would be both trader and investor into this counter at this price.'